Welcome to LookChem.com Sign In|Join Free
  • or
2-Propen-1-one, 3-(4-pyridinyl)-1-(3,4,5-trimethoxyphenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61196-72-3

Post Buying Request

61196-72-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61196-72-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61196-72-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,1,9 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 61196-72:
(7*6)+(6*1)+(5*1)+(4*9)+(3*6)+(2*7)+(1*2)=123
123 % 10 = 3
So 61196-72-3 is a valid CAS Registry Number.

61196-72-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-pyridin-4-yl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61196-72-3 SDS

61196-72-3Relevant academic research and scientific papers

Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia

Puxeddu, Michela,Shen, Hongliang,Bai, Ruoli,Coluccia, Antonio,Bufano, Marianna,Nalli, Marianna,Sebastiani, Jessica,Brancaccio, Diego,Da Pozzo, Eleonora,Tremolanti, Chiara,Martini, Claudia,Orlando, Viviana,Biagioni, Stefano,Sinicropi, Maria Stefania,Ceramella, Jessica,Iacopetta, Domenico,Coluccia, Addolorata Maria Luce,Hamel, Ernest,Liu, Te,Silvestri, Romano,La Regina, Giuseppe

, (2021)

Long-term survivors of glioblastoma multiforme (GBM) are at high risk of developing second primary neoplasms, including leukemia. For these patients, the use of classic tyrosine kinase inhibitors (TKIs), such as imatinib mesylate, is strongly discouraged,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61196-72-3